The stock of Neurogene Inc (NASDAQ: NGNE) has decreased by -6.12 when compared to last closing price of 33.64.Despite this, the company has seen a loss of -17.61% in its stock price over the last five trading days.
Is It Worth Investing in Neurogene Inc (NASDAQ: NGNE) Right Now?
The 36-month beta value for NGNE is at 1.37. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NGNE is 11.51M, and currently, shorts hold a 7.87% of that float. The average trading volume for NGNE on April 19, 2024 was 140.84K shares.
NGNE’s Market Performance
NGNE’s stock has seen a -17.61% decrease for the week, with a -29.92% drop in the past month and a 4.60% gain in the past quarter. The volatility ratio for the week is 8.55%, and the volatility levels for the past 30 days are at 7.31% for Neurogene Inc The simple moving average for the past 20 days is -27.19% for NGNE’s stock, with a 43.73% simple moving average for the past 200 days.
Analysts’ Opinion of NGNE
Many brokerage firms have already submitted their reports for NGNE stocks, with William Blair repeating the rating for NGNE by listing it as a “Outperform.” The predicted price for NGNE in the upcoming period, according to William Blair is $61 based on the research report published on March 21, 2024 of the current year 2024.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see NGNE reach a price target of $45. The rating they have provided for NGNE stocks is “Buy” according to the report published on January 08th, 2024.
Stifel gave a rating of “Buy” to NGNE, setting the target price at $31 in the report published on January 05th of the current year.
NGNE Trading at -15.53% from the 50-Day Moving Average
After a stumble in the market that brought NGNE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.42% of loss for the given period.
Volatility was left at 7.31%, however, over the last 30 days, the volatility rate increased by 8.55%, as shares sank -29.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.31% lower at present.
During the last 5 trading sessions, NGNE fell by -17.61%, which changed the moving average for the period of 200-days by +91.37% in comparison to the 20-day moving average, which settled at $42.71. In addition, Neurogene Inc saw 62.95% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NGNE
The total capital return value is set at -0.33. Equity return is now at value -25.91, with -21.46 for asset returns.
Based on Neurogene Inc (NGNE), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -19.59. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -2074.88.
Currently, EBITDA for the company is -49.36 million with net debt to EBITDA at 2.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.72.
Conclusion
In conclusion, Neurogene Inc (NGNE) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
